These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 29187163

  • 1. Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection.
    Chang YJ, Lee MS, Lee CH, Lin PC, Kuo FC.
    BMC Infect Dis; 2017 Nov 29; 17(1):736. PubMed ID: 29187163
    [Abstract] [Full Text] [Related]

  • 2. Methicillin-resistant Staphylococcal periprosthetic joint infections can be effectively controlled by systemic and local daptomycin.
    Kuo FC, Yen SH, Peng KT, Wang JW, Lee MS.
    BMC Infect Dis; 2016 Feb 01; 16():48. PubMed ID: 26830838
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections.
    Corona Pérez-Cardona PS, Barro Ojeda V, Rodriguez Pardo D, Pigrau Serrallach C, Guerra Farfán E, Amat Mateu C, Flores Sanchez X.
    J Antimicrob Chemother; 2012 Jul 01; 67(7):1749-54. PubMed ID: 22511636
    [Abstract] [Full Text] [Related]

  • 4. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series.
    Rao N, Regalla DM.
    Clin Orthop Relat Res; 2006 Oct 01; 451():34-7. PubMed ID: 16735866
    [Abstract] [Full Text] [Related]

  • 5. Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.
    Saleh-Mghir A, Muller-Serieys C, Dinh A, Massias L, Crémieux AC.
    Antimicrob Agents Chemother; 2011 Oct 01; 55(10):4589-93. PubMed ID: 21825285
    [Abstract] [Full Text] [Related]

  • 6. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ.
    Clin Ther; 2016 Jan 01; 38(1):16-30. PubMed ID: 26585355
    [Abstract] [Full Text] [Related]

  • 7. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A, Cafiso V, Campanile F, Parisi G, Mariani B, Petrosillo N, Stefani S.
    Eur J Clin Microbiol Infect Dis; 2016 Apr 01; 35(4):625-31. PubMed ID: 26815434
    [Abstract] [Full Text] [Related]

  • 8. Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty.
    Byren I, Rege S, Campanaro E, Yankelev S, Anastasiou D, Kuropatkin G, Evans R.
    Antimicrob Agents Chemother; 2012 Nov 01; 56(11):5626-32. PubMed ID: 22908174
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus.
    Antony SJ.
    Scand J Infect Dis; 2006 Nov 01; 38(4):293-5. PubMed ID: 16718933
    [Abstract] [Full Text] [Related]

  • 11. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ.
    Clin Infect Dis; 2013 Jun 01; 56(11):1562-9. PubMed ID: 23449272
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
    Jacobson LM, Milstone AM, Zenilman J, Carroll KC, Arav-Boger R.
    Pediatr Infect Dis J; 2009 May 01; 28(5):445-7. PubMed ID: 19295462
    [Abstract] [Full Text] [Related]

  • 14. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS, McDermott BP, Cunha BA.
    Heart Lung; 2005 May 01; 34(1):69-71. PubMed ID: 15647736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study.
    Lora-Tamayo J, Parra-Ruiz J, Rodríguez-Pardo D, Barberán J, Ribera A, Tornero E, Pigrau C, Mensa J, Ariza J, Soriano A.
    Diagn Microbiol Infect Dis; 2014 Sep 01; 80(1):66-71. PubMed ID: 24996840
    [Abstract] [Full Text] [Related]

  • 17. Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.
    Leijtens B, Elbers JBW, Sturm PD, Kullberg BJ, Schreurs BW.
    BMC Infect Dis; 2017 May 02; 17(1):321. PubMed ID: 28464821
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections.
    Joseph WS, Quast T, Cogo A, Crompton MG, Yoon MJ, Lamp KC, Culshaw D, Chaves RL.
    J Am Podiatr Med Assoc; 2014 Mar 02; 104(2):159-68. PubMed ID: 24725036
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.